Search Results
The challenges of treating patients with MPNs who possess a TP53 mutation
The prognostic impact of TP53 mutation in MPNs
Why MPNs Transform to AML
TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles
The impact of TP53 mutation on treatment approaches in MCL
Dr. Jason Gotlib, MD, MS - Molecular Mutations in MPNs: Impact on Treatment
Testing for IgHV and TP53 mutations to guide treatment decisions in CLL
Why MPN transforms to AML
Use of Molecular Genetic Testing in MDS and MPN
Identifying low-burden TP53 mutations with NGS in CLL
Dr. Pemmaraju on Methods to Treat Anemia in MPNs
The need for disease-modifying therapies in MPNs
